| 英文别名 |
6α-Hydroxy Norgestrel;6α-Hydroxy Levonorgestrel;(6R,13S,17R)-13-ethyl-17-ethynyl-6,17-dihydroxy-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one;6A-HYDROXY NORGESTREL;6A-HYDROXYLEVONORGESTREL;6Alpha-Hydroxy Norgestrel;6alpha-Hydroxylevonorgestrel;IDV1AQL73M;13-Ethyl-6alpha,17-dihydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one (6alpha-Hydroxylevonorgestrel);Levonorgestrel Imp. G (EP); 13-Ethyl-6alpha,17-dihydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one; Levonorgestrel Imp. G (Pharmeuropa); 6alpha-Hydroxylevonorgestrel; Levonorgestrel Impurity G;(6S,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-6,17-dihydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one;AKOS032958185;Levonorgestrel impurity G [EP];13-Ethyl-6alpha,17-dihydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one;18,19-DINORPREGN-4-EN-20-YN-3-ONE, 13-ETHYL-6,17-DIHYDROXY-, (6.ALPHA.,17.ALPHA.)-;6.ALPHA.-HYDROXYLEVONORGESTREL;Levonorgestrel Impurity G (6-alpha-Hydroxy Levonorgestrel);13-ETHYL-6.ALPHA.,17-DIHYDROXY-18,19-DINOR-17.ALPHA.-PREGN-4-EN-20-YN-3-ONE;6alpha-Hydroxy Levonorgestrel;LEVONORGESTREL IMPURITY G [EP IMPURITY];UNII-IDV1AQL73M;87585-03-3;18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-6,17-dihydroxy-, (6alpha,17alpha)- |
